ArticleThe oncologist2024

Investigating risk factors and treatment options for severe, partially steroid responsive, and steroid-refractory checkpoint inhibitor pneumonitis.

Meghana Moodabagil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.